Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Nature Communications|May 20, 2025
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndromeHiroki Mizumaki, Shouguo Gao, Zhijie Wu, et al.Haematologica|January 8, 2026
Telomere attrition is common in patients with germline <i>RUNX1</i> pathogenic variantsRialnat A Lawal, Fernanda Gutierrez-Rodrigues, David J Young, et al.Frontiers in Cell and Developmental Biology|November 15, 2021
Possible Involvement of Hsp90 in the Regulation of Telomere Length and Telomerase Activity During the <i>Leishmania amazonensis</i> Developmental Cycle and Population ProliferationBeatriz C D de Oliveira, Mark E Shiburah, Stephany C Paiva, et al.Haematologica|December 29, 2022
Effects of nandrolone decanoate on telomere length and clinical outcome in patients with telomeropathies: a prospective trialDiego V Clé, Luiz Fernando B Catto, Fernanda Gutierrez-Rodrigues, et al.Frontiers in Cell and Developmental Biology|May 2, 2022
Corrigendum: Possible Involvement of Hsp90 in the Regulation of Telomere Length and Telomerase Activity During the <i>Leishmania Amazonensis</i> Developmental Cycle and Population ProliferationBeatriz C D de Oliveira, Mark E Shiburah, Stephany C Paiva, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Pathogenic TERT promoter variants in telomere diseasesFernanda Gutierrez-Rodrigues, Flávia S Donaires, André Pinto, et al.Blood|June 25, 2025
Clinical and molecular features of immunodeficiency in patients with telomere biology disordersLuiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, et al.Blood Advances|April 25, 2020
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopeniasXing Fan, Ronan Desmond, Thomas Winkler, et al.Leukemia|July 27, 2022
Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemiaEmma M Groarke, Bhavisha A Patel, Ruba Shalhoub, et al.Haematologica|December 1, 2020
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndromeAlana Vicente, Bhavisha A Patel, Fernanda Gutierrez-Rodrigues, et al.Pageof 5